The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study

We aimed to characterize non-oncologic chronic drug therapy of bladder cancer (BC) patients and evaluate a possible impact on recurrence-free (RFS) and cancer-specific survival (CSS). Patients with a first diagnosis (FD) of BC or radical cystectomy (RC) were included in a prospective, monocentric, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Strobach, Dorothea, Haimerl, Lisa, Mannell, Hanna, Stief, Christian G., Karl, Alexander, Grimm, Tobias, Buchner, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648271/
https://www.ncbi.nlm.nih.gov/pubmed/37959213
http://dx.doi.org/10.3390/jcm12216749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648271/
https://www.ncbi.nlm.nih.gov/pubmed/37959213
http://dx.doi.org/10.3390/jcm12216749

Ejemplares similares